These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1663926)

  • 1. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone resistance from a transferable plasmid.
    Martínez-Martínez L; Pascual A; Jacoby GA
    Lancet; 1998 Mar; 351(9105):797-9. PubMed ID: 9519952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens.
    Watanabe M; Kotera Y; Yosue K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jan; 34(1):173-5. PubMed ID: 2183709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
    Masecar BL; Robillard NJ
    Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of quinolone resistance mechanisms in Enterobacteriaceae isolated from companion animals in Europe (ComPath II study).
    de Jong A; Muggeo A; El Garch F; Moyaert H; de Champs C; Guillard T
    Vet Microbiol; 2018 Mar; 216():159-167. PubMed ID: 29519511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broader distribution of plasmid-mediated quinolone resistance in the United States.
    Robicsek A; Sahm DF; Strahilevitz J; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3001-3. PubMed ID: 15980384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteins.
    Deguchi T; Yasuda M; KawamuraT ; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Kawada Y
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2544-6. PubMed ID: 9371364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
    Xu X; Wu S; Ye X; Liu Y; Shi W; Zhang Y; Wang M
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4105-10. PubMed ID: 17724159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.
    Weigel LM; Steward CD; Tenover FC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2661-7. PubMed ID: 9756773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
    Sanders CC; Sanders WE; Goering RV; Werner V
    Antimicrob Agents Chemother; 1984 Dec; 26(6):797-801. PubMed ID: 6098219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.
    Thomson KS; Sanders CC; Hayden ME
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2329-34. PubMed ID: 1804005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
    Levy DD; Sharma B; Cebula TA
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2355-63. PubMed ID: 15215081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the outer membrane for quinolone resistance in enterobacteria.
    Dechène M; Leying H; Cullmann W
    Chemotherapy; 1990; 36(1):13-23. PubMed ID: 2106416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
    Ruiz J; Gómez J; Navia MM; Ribera A; Sierra JM; Marco F; Mensa J; Vila J
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):257-61. PubMed ID: 12007443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Klebsiella pneumoniae and Enterobacter cloacae with fluoroquinolone resistance-associated amino acid alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Kawamura T; Takahashi Y; Okezaki E; Nagata O; Kato H; Kawada Y
    J Antimicrob Chemother; 1997 Dec; 40(6):907-9. PubMed ID: 9462448
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98.
    Robert J; Cambau E; Grenet K; Trystram D; Péan Y; Fiévet MH; Jarlier V
    Clin Microbiol Infect; 2001 Oct; 7(10):553-61. PubMed ID: 11683796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of high-level quinolone resistance in Campylobacter jejuni.
    Gootz TD; Martin BA
    Antimicrob Agents Chemother; 1991 May; 35(5):840-5. PubMed ID: 1649570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain.
    Alarcón T; Pita J; López-Brea M; Piddock LJ
    J Antimicrob Chemother; 1993 Oct; 32(4):605-9. PubMed ID: 8288502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.